Cytodyn Inc (CYDY)

[LongTkt]

Bobbythebus is too funny

I showed the MID TERM ($330/share) & LONG TERM ($550/share with PE=50) outlook on CYDY stock due to potential COVID revenue. That upside potential is not going to scare anyone away for a $5 a share stock.

I think Leronlimab is going to be locked up in patents for many many years.

Look at the revenue potential for the future Leronlimab treatment list

Maybe this was scary? I pointed out that something was going on between BP and NP. Then weeks later we learned from them NP DrBeen interview they had a business disagreement.

Newbie LONG investors should be scared seeing such big $$$. It can be life changing.